Paper80265
Copper(II)-binding ability of human alpha-fetoprotein.
Aoyagi Y and 2 others. Cancer Res, 1978. Cited by 52 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Copper(II)-binding ability of human alpha-fetoprotein. Papers, record 80265. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/80265
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Copper | Major topic |
| alpha-Fetoproteins | Major topic |
| Carcinoma, Hepatocellular | |
| Fetal Blood | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Liver Neoplasms | |
| Nickel | |
| Photochemistry |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,801,276 | Properties of the major Zn2+-binding site of human alpha-fetoprotein, a potential foetal plasma zinc carrier. | Chem Commun (Camb) | 2025 | https://conductscience.org/library/papers/39801276 | PubMed |
| 38,678,117 | Structural characteristics of alpha-fetoprotein, including N-glycosylation, metal ion and fatty acid binding sites. | Commun Biol | 2024 | https://conductscience.org/library/papers/38678117 | PubMed |
| 36,301,669 | Mitochondrial dysfunction reactivates α-fetoprotein expression that drives copper-dependent immunosuppression in mitochondrial disease models. | J Clin Invest | 2023 | https://conductscience.org/library/papers/36301669 | PubMed |
| 26,586,174 | Plasma proteomic analysis of active and torpid greater mouse-eared bats (Myotis myotis). | Sci Rep | 2015 | https://conductscience.org/library/papers/26586174 | PubMed |
| 23,765,762 | Alpha-fetoprotein: a renaissance. | Tumour Biol | 2013 | https://conductscience.org/library/papers/23765762 | PubMed |
| 19,549,813 | Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. | Physiol Genomics | 2009 | https://conductscience.org/library/papers/19549813 | PubMed |
| 7,021,400 | The use of glycylhistidyllysine in culture systems. | In Vitro | 1981 | https://conductscience.org/library/papers/7021400 | PubMed |
| 6,162,454 | High affinity of alpha-foetoprotein for arachidonate and other fatty acids. | Biochem J | 1980 | https://conductscience.org/library/papers/6162454 | PubMed |
| 2,467,660 | Synthesis and copper(II)-binding properties of the N-terminal peptide of human alpha-fetoprotein. | Biochem J | 1989 | https://conductscience.org/library/papers/2467660 | PubMed |
| 2,434,121 | Close topographical relationship in alpha foetoprotein (AFP) between a lens culinaris binding glycan and the epitope recognized by AFP-reactive monoclonal antibody, 18H4. | Br J Cancer | 1987 | https://conductscience.org/library/papers/2434121 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AFP | 174 | Swiss-Prot's references | https://conductscience.org/library/genes/174 | NCBI Gene |
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/80265
GET https://conductscience.org/api/papers/v1/80265/authors